Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze, P Kakkadasam… - Nature Reviews …, 2020 - nature.com
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …
被引用次数：67 相关文章

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze, P Kakkadasam… - Nature Reviews …, 2020 - elibrary.ru
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

A Marjorie, PG Kotze, K Pradeep - Nature Reviews …, 2020 - search.proquest.com
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze, P Kakkadasam… - Nature reviews …, 2020 - dora.health.qld.gov.au
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze… - Nature reviews …, 2020 - pubmed.ncbi.nlm.nih.gov
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze, P Kakkadasam… - Nature reviews …, 2020 - europepmc.org
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze… - Nature …, 2020 - researchinformation.amsterdamumc …
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze, P Kakkadasam… - Nature Reviews …, 2020 - go.gale.com
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …
[PDF] researchgate.net

[PDF][PDF] Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze, P Kakkadasam, G D'Haens - researchgate.net
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …